Markers of Atrial Cardiopathy in Severe Embolic Strokes of Undetermined Source

Maurizio Acampa1, Alessandra Cartocci2, Carlo Domenichelli1

  • 1Stroke Unit, Department of Emergency-Urgency and Transplants, Azienda Ospedaliera Universitaria Senese, "Santa Maria alle Scotte" General Hospital, Siena, Italy.

Insights

Severe embolic strokes of undetermined source (ESUS) are linked to older age, female sex, and atrial cardiopathy markers. Identifying these factors is crucial for appropriate patient management and therapy.

Area of Science:

  • Cardiology
  • Neurology
  • Stroke Research

Background:

  • Embolic strokes of undetermined source (ESUS) encompass diverse etiological mechanisms.
  • Current ESUS definitions may be too broad, potentially masking specific underlying causes like atrial cardiopathy.
  • Heterogeneous mechanisms within ESUS can influence clinical stroke severity.

Purpose of the Study:

  • To investigate the association between neurological deficit severity in ESUS patients and the presence of atrial cardiopathy markers.
  • To identify specific clinical characteristics associated with severe ESUS.

Main Methods:

  • Retrospective analysis of 226 ESUS patients, categorized by neurological deficit severity (NIHSS ≤ 5 vs. >5).
  • Evaluation of atrial cardiopathy indices including P wave dispersion, P wave characteristics, and left atrial size.
  • Multivariate logistic regression to determine predictors of severe ESUS.

Main Results:

  • Severe ESUS patients were older, predominantly female, and exhibited higher P wave dispersion, P wave max, P wave index, and left atrial size compared to mild ESUS.
  • An abnormal P wave axis was more frequent in the severe ESUS group.
  • Multivariate analysis identified age, female sex, and P wave dispersion as significant predictors of severe ESUS.

Conclusions:

  • Atrial cardiopathy markers are associated with increased neurological deficit severity in ESUS.
  • These findings suggest atrial cardiopathy may play a pathogenic role in a specific subgroup of severe ESUS patients.
  • Early detection of atrial fibrillation in these patients is critical for optimal therapeutic strategies.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
43
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
50
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
116
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
327
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
49